Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

The Lancet Rheumatology, 2022
Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study

Clark K., Csomor E., Campochiaro C. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasmaInterstitial Fluid (skin blisters)

Clinical Infectious Diseases, 2022
Perinatally Human Immunodeficiency Virus–Infected Adolescents and Young Adults Demonstrate Distinct BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine Immunogenicity

Morrocchi E., Pighi C., Pascucci G. et al.

Olink Target 96Infectious DiseasesPatient StratificationPlasma

Molecular Metabolism, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolism

Ho M., Zhang C., Moon I. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPatient StratificationPlasma

iScience, 2022
Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19

Buyukozkan M., Alvarez-Mulett S., Racanelli A. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationSerum

Brain and Spine, 2022
Cerebrospinal fluid and peripheral blood proteomics in Traumatic Spinal Cord Injury: A prospective pilot study

Wichmann T., Kasch H., Dyrskog S. et al.

Olink Target 96NeurologyPathophysiologyPlasmaCSF

Journal of Neuroendocrinology, 2022
Plasma protein biomarkers for the detection of pancreatic neuroendocrine tumors and differentiation from small intestinal neuroendocrine tumors

Thiis‐Evensen E., Kjellman M., Knigge U. et al.

Olink Target 96OncologyPatient StratificationPlasma

Brain Communications, 2022
Plasma biomarkers for prognosis of cognitive decline in patients with mild cognitive impairment

Kivisäkk P., Magdamo C., Trombetta B. et al.

Olink Target 96NeurologyPatient StratificationPlasma

Scientific Reports, 2022
Association of FXI activity with thrombo-inflammation, extracellular matrix, lipid metabolism and apoptosis in venous thrombosis

Pallares Robles A., ten Cate V., Schulz A. et al.

Olink Target 96CVDPathophysiologyPlasma

British Journal of Haematology, 2022
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease

Pratta M., Paczesny S., Socie G. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologyPlasma

Scientific Reports, 2022
Targeted proteomics of appendicular skeletal muscle mass and handgrip strength in black South Africans: a cross-sectional study

Dlamini S., Norris S., Mendham A. et al.

Olink Target 96Other Diseases & SyndromesPathophysiologyPlasma

Arthritis & Rheumatology, 2022
Serologic Biomarkers of Progression Toward Diagnosis of Rheumatoid Arthritis in Active Component Military Personnel

Loza M., Nagpal S., Cole S. et al.

Olink Target 96Immunological & Inflammatory DiseasesPatient StratificationPlasma

Nature Communications, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Damsky W., Wang A., Kim D. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesPathophysiologyPlasma

Communications Biology, 2022
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort

Yang J., Jia Z., Song X. et al.

Olink Target 96Other Diseases & SyndromesPatient StratificationPlasma

Frontiers in Neurology, 2022
Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease

Carlyle B., Kitchen R., Mattingly Z. et al.

Olink Target 96NeurologyTechnical EvaluationPlasma

Nature Medicine, 2022
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial

Padrón L., Maurer D., O’Hara M. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Brain, 2022
A Mendelian randomization study investigating the causal role of inflammation on Parkinson’s disease

Bottigliengo D., Foco L., Seibler P. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Kidney Medicine, 2022
Plasma Kidney Injury Molecule-1 in Systemic Lupus Erythematosus: Discordance Between ELISA and Proximity Extension Assay

Schmidt I., Colona M., Srivastava A. et al.

Olink Target 96Immunological & Inflammatory DiseasesTechnical EvaluationPlasma

Scandinavian Journal of Immunology, 2022
The Karolinska KI/K COVID‐19 immune atlas: An open resource for immunological research and educational purposes

Ljunggren H., Heggernes Ask E., Cornillet M. et al.

Olink Target 96Infectious DiseasesPathophysiologyPatient StratificationPlasma

Nature Communications, 2022
Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Liu J., Wang Y., Tian Z. et al.

Olink Target 96OncologyImmunotherapyPatient StratificationPlasma

Journal of the American College of Cardiology, 2022
Precision Phenotyping of Dilated Cardiomyopathy Using Multidimensional Data

Tayal U., Verdonschot J., Hazebroek M. et al.

Olink Target 96CVDPatient StratificationSerum

3026 publications